🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Hussein Tawbi, MD, PhD starting the exciting brain met session discussing symtomatic vs asymptomatic states and their implications #EANO2024

Thank you much for invitation Manuel Valiente, great conference. Looking forward to working w u EANO #SNO CIMARa to arrive to a consensus on symptomatic vs asymptomatic brain metastases. Critical step for drug development in this poorly represented population

Advanced Melanoma: Optimizing ICI-Based Therapies activity is now live on OncologyCE. Click here to access this free CME activity Hussein Tawbi, MD, PhD and I led. Thanks to Vindico Medical Education for a great program!  healio.com/cme/oncologyce…

Comprehensive and exciting overview of neoadjuvant PD-1+LAG-3 data in melanoma, lung, and beyond. Liz Burton, PhD has done extensive biomarker analyses and highlights some familiar (B cells, IFN) and some novel (TIGIT, B7-H3) markers. B7-H3 is quite novel and potentially targetable!

WORK HARD, PLAY HARD! #Immunotherapy #Bridge2024 is over & the 15th #Melanoma Bridge. Great being in Napoli with so many friends.Paolo A. Ascierto Toni Choueiri, MD Omid Hamid MD Hussein Tawbi, MD, PhD Allison Betof Warner, MD, PhD Tullia Bruno, PhD Samir N. Khleif, MD Society for Immunotherapy of Cancer Jerome GALON Avery Posey Jennifer Guerriero, PhD #Napoli

It’s Starting!! DAY 2 of #Melanoma #Bridge2024 in #Napoli #italia Paolo A. Ascierto Society for Immunotherapy of Cancer #FinishCancer

Calling all oncologists📣Evaluate the latest data to support neoadjuvant and adjuvant immunotherapy for metastatic melanoma with this #CME activity: ow.ly/93Ka50UgF4I @meredithmckean Tara C Mitchell Hussein Tawbi, MD, PhD Merck #Oncology

5 distinguished students from our #TrEd_Team_AUB will be giving clinics for 5 chemistry undergraduate courses during this semester American University of Beirut: Seungju Moon: Chem 201 Rony Diab: Chem 208 Layana Takieddine: Chem 211 Karam Al-Gharib: Chem 212 Lynn El-Zoghby: Chem 218 #TrEd

BIG-NCTN is excited to collaborate with ABC Global Alliance on the brain Mets HUB! If you have suggestions for links/webpages to include, please send them to [email protected] where they will be curated as the HUB is built out. Seamus O’Reilly MD PhD Breast International Group Carey Anders

A pleasure to connect with Canadian & international colleagues & presenting on Targeted Therapy in Melanoma. Many thanks to Profs Teresa Petrella & Vanessa Bernstein for hosting yet another wonderful Canadian Melanoma Conference #CMC in beautiful Vancouver!

Ahmad Tarhini, MD, PhD, and Hussein A. Tawbi, MD, PhD, discussed data from the RELATIVITY-047 and CheckMate 076 trial for patients with melanoma. #melsm | Ahmad Tarhini Hussein Tawbi, MD, PhD cancernetwork.com/view/nivolumab…

View our top 5 articles of the week: FDA Aditya Bardia, MD Wenxin (Vincent) Xu Ahmad Tarhini Hussein Tawbi, MD, PhD ASCO 1. cancernetwork.com/view/expert-in… 2. cancernetwork.com/view/a-look-at… 3. cancernetwork.com/view/nivolumab… 4. cancernetwork.com/view/belzutifa… 5. cancernetwork.com/view/fish-oil-…

Last week’s Melanoma Research Retreat was an oasis of unabashed science in the midst of current gloom: ground breaking science, unpublished data, keynotes on success in neoadjuvant and challenges in targeting NRAS! I had the honor of moderating the closing panel with amazing

New #JITC article: FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma bit.ly/4jbtl6r Serigne Lo Liz Burton, PhD Hussein Tawbi, MD, PhD David Gyorki MD Anderson Cancer Center

Hussein Tawbi, MD, PhD Melanoma Research Huge thanks to the brilliant minds behind it all—Jason Luke, MD, FACP, Allison Betof Warner, MD, PhD, Dr. Ott, Dr. Merghoub, Hussein Tawbi, MD, PhD & many more. You left me not just hopeful—but more determined than ever to help turn science into survival. #MelanomaWarrior #SurvivorStrong #MRA2025 #thriver

Two weeks from today, our #TrEd team will be rocking American University of Beirut campus with grandiose chemistry experiments in our #ChemCarnival on May 23rd. Our ChemCarnival is open to the public & is free of charge. #TransformativeEducation #ElevatingCommunity

Watch Hussein Tawbi, MD, PhD (Hussein Tawbi, MD, PhD), Prof. Paolo Antonio Ascierto, MD & Isabella C. Glitza Oliva, MD, PhD discuss the latest #melanoma updates from #ASCO25 - to participate, visit: bit.ly/MM25-T x.com/i/broadcasts/1…

At 12 p.m. on Monday, June 2, a group of experts will be in booth 10059 to share the latest in immunotherapy treatment for metastatic melanoma. #ASCO25 #EndCancer (4/7) Hussein Tawbi, MD, PhD

🔔Make sure to check out our study!! ASCO #ASCO25 ⭐️#HighFiber (HF) #diet to modulate microbiome and outcomes in #immunotherapy in #Melanoma ✅ORR: ⬆️HF 77% Cntrl 29% ✅No significant GI related or Immune related AEs with HF diet ✅Cutaneous adverse events⬇️ w HF ✅ impressive